Evidence map›Paper›PMID 41288142›Full record

ReviewThe Laryngoscope2026

What Is the Best Approach for the Management of Mental Health Disease Among Head and Neck Cancer Patients?

Matthew E Lin, Lauran Evans, Desiree Delavary, David Rapkin, Maie St John

Abstract readReview
In one paragraph

Review in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matthew E LinDepartment of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, California, Los Angeles, USA.ORCID 0000-0001-9914-9670
Lauran EvansDepartment of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, California, Los Angeles, USA.
Desiree DelavaryA.T. Still University School of Osteopathic Medicine in Arizona, Mesa, Arizona, USA.
David RapkinDepartment of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, California, Los Angeles, USA.
Maie St JohnDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0001-7068-9534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although patients with head and neck cancer (HND) commonly experience mental health disease (MHD) at rates equal to or greater than those of patients with other types of cancer, HNC patients with MHD are often underdiagnosed and untreated. Thus, validated surveys should be used to screen for MHD, as subjective clinical judgement may underdiagnose MHD. Multidisciplinary treatment through psychosocial interventions and antidepressant medications can lead to lower rates of MHD, improved quality of life, and reduced mortality among HNC patients.

Indexed as

Head and Neck NeoplasmsMental DisordersAntidepressive AgentsHumansQuality of LifeAntidepressive Agentsanxietycancerdepressionhead and neckmental healthquality of lifesurvivorship

Identifiers

PMID41288142
PMCPMC13357357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.